乌鸦传媒

With few exceptions, treatment can be shortened to 7 days, researcher says

Fewer cerebral ischemic events also observed with care teams quicker to give blood

Temperature management device did result in less fever in the INTREPID trial

Our fragile patients are increasingly dependent on a crumbling healthcare system

To some extent, it's to be expected, researchers note

Clinicians must "uncomfortably" examine bias in life-and-death decisions, says expert

False positives, alarm fatigue complicate their use, experts say

Harms seen without any compensating survival benefit

Benefit limited to patients with severe illness or elevated minimum inhibitory concentrations

At-risk older adults should be screened, referred early for rehabilitation, researcher urges

Randomized trial failed to get anywhere near tight glucose control

Secondary findings of trial only suggest a potential benefit in kidney protection

But expert still suggests the approach may not be appropriate for the most severely ill

However, treated patients were less likely to develop ARDS, respiratory dysfunction